25 Feb 2013
(MENAFN) Gulf Pharmaceutical Industries (Julphar) announced that 2012’s profit climbed by 17.6 percent to USD54.50 million, reported Khaleej Times.
Meanwhile, operating profit went up by 8.6 percent from a year before to USD59.12 million.
The company added that gross profit grew by 11.1 percent in the year, reaching USD189.85 million, while operating profit margin was at 18.4 percent.
It is worth noting that Julphar’s sales revenue climbed by 15.3 percent from 2011, reaching USD321 million, as tender market sales increased by 22.5 percent.
13 Apr 2026
BBK launches the Youth Advisory Council (YAC) to empower youth and advance innovation
08 Apr 2026
BBK awards over BD 1 Million to 273 winners in the February Al Hayrat Grand Prizes draw
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more